Search Results
Luspatercept compared with other available therapies for MF
ACE-536-MF-001 update: luspatercept for the treatment of anemia in myelofibrosis
Luspatercept benefits MF-associated anemia
How might luspatercept benefit patients with myelofibrosis?
Luspatercept in RBC transfusion-dependent MF patients
Overall survival of patients following treatment with luspatercept in the MEDALIST trial
Luspatercept for MDS-associated anemia
Phase II trial of luspatercept in myelofibrosis-associated anemia
COMMANDS: luspatercept versus epoetin alfa in LR-MDS-associated anemia - results & caveats
INDEPENDENCE: luspatercept vs placebo in MPNs-associated myelofibrosis
MEDALIST: OS & risk of disease progression in patients with MDS treated with luspatercept
An efficacy sub-analysis from the ACE-536-MF-001 study of luspatercept for MF-related anemia
